1,021.65
-8.30
(-0.81%)
At close: January 28 at 3:30:01 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
59,117,400.00
53,094,800.00
44,889,500.00
38,831,900.00
24,824,100.00
Cost of Revenue
12,381,100.00
11,179,500.00
9,211,000.00
9,229,000.00
5,944,100.00
Gross Profit
46,736,300.00
41,915,300.00
35,678,500.00
29,602,900.00
18,880,000.00
Operating Expense
33,110,800.00
28,948,500.00
25,226,100.00
21,667,300.00
15,991,800.00
Operating Income
13,625,500.00
12,966,800.00
10,452,400.00
7,935,600.00
2,888,200.00
Net Non Operating Interest Income Expense
556,400.00
963,100.00
285,200.00
-257,800.00
-1,027,300.00
Pretax Income
13,904,100.00
13,653,200.00
10,637,200.00
7,389,000.00
-686,500.00
Tax Provision
3,314,500.00
3,076,800.00
-397,900.00
1,338,500.00
458,500.00
Net Income Common Stockholders
10,589,600.00
10,576,400.00
11,035,100.00
6,050,500.00
-1,375,500.00
Diluted NI Available to Com Stockholders
10,589,600.00
10,576,400.00
11,035,100.00
6,050,500.00
-1,375,500.00
Basic EPS
10.90
10.89
11.38
6.25
-1.59
Diluted EPS
10.84
10.84
11.36
6.24
-1.59
Basic Average Shares
971,893.44
971,566.37
970,063.79
967,465.37
863,195.97
Diluted Average Shares
976,703.87
975,458.59
971,710.92
969,382.72
863,195.97
Rent Expense Supplemental
--
236,700.00
250,200.00
188,500.00
160,100.00
Total Expenses
45,491,900.00
40,128,000.00
34,437,100.00
30,896,300.00
21,935,900.00
Net Income from Continuing & Discontinued Operation
10,589,600.00
10,576,400.00
11,035,100.00
6,050,500.00
-1,375,500.00
Normalized Income
10,871,931.45
10,863,561.36
11,155,500.00
6,327,026.44
568,330.00
Interest Income
1,450,300.00
1,562,000.00
1,123,800.00
750,900.00
767,300.00
Interest Expense
740,600.00
445,600.00
713,200.00
900,100.00
1,710,000.00
Net Interest Income
556,400.00
963,100.00
285,200.00
-257,800.00
-1,027,300.00
EBIT
14,644,700.00
14,098,800.00
11,350,400.00
8,289,100.00
1,023,500.00
EBITDA
17,568,000.00
16,548,600.00
13,672,300.00
10,500,300.00
2,764,400.00
Reconciled Cost of Revenue
12,381,100.00
11,179,500.00
9,211,000.00
9,229,000.00
5,944,100.00
Reconciled Depreciation
2,923,300.00
2,449,800.00
2,321,900.00
2,211,200.00
1,740,900.00
Net Income from Continuing Operation Net Minority Interest
10,589,600.00
10,576,400.00
11,035,100.00
6,050,500.00
-1,375,500.00
Total Unusual Items Excluding Goodwill
-370,700.00
-370,700.00
-172,000.00
-337,700.00
-2,776,900.00
Total Unusual Items
-370,700.00
-370,700.00
-172,000.00
-337,700.00
-2,776,900.00
Normalized EBITDA
17,938,700.00
16,919,300.00
13,844,300.00
10,838,000.00
5,541,300.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-88,368.55
-83,538.64
-51,600.00
-61,173.56
-833,070.00
3/31/2021 - 8/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MEDANTA.NS Global Health Limited
1,017.70
-0.33%
NH.NS Narayana Hrudayalaya Limited
1,269.10
-1.81%
APOLLOHOSP.NS Apollo Hospitals Enterprise Limited
6,708.95
+0.20%
FORTIS.NS Fortis Healthcare Limited
581.20
-1.82%
JLHL.NS Jupiter Life Line Hospitals Limited
1,522.00
-0.57%
RAINBOW.NS Rainbow Children's Medicare Limited
1,374.85
-2.13%
MAXIND.NS Max India Limited
243.05
-2.76%
ASTERDM.NS Aster DM Healthcare Limited
473.45
-3.11%
YATHARTH.BO Yatharth Hospital & Trauma Care Services Limited
412.50
-2.72%
HCG.NS HealthCare Global Enterprises Limited
491.85
-1.32%